WORKING GROUP ON MENINGOCOCCAL VACCINATIONS


MEMBERS OF THE WORKING GROUP

 
       
➡️ Simon_Kroll.jpg   Prof. Simon Kroll, Professor of Paediatrics and Molecular Infectious Diseases, Imperial College and St Mary’s Hospital, Member of the UK Health Protection Agency Meningococcus Forum, United Kingdom
➡️ PHILIPPE_DE_wals.png   Philippe de Wals, Professor and Director of the Department of Social and Preventive Medicine at Laval University, Quebec, Canada
➡️   Irene Rivero-Calle, Consultant in Pediatrics and Pediatric Infectious Diseases, University Clinical Hospital of Santiago de Compostela, Spain
➡️   Elena Moya, Co-ordinator for Europe and Africa - COMO - Confederation of Meningitis Organisations, Spain
➡️   Daphne Holt, Coalition for Life-Course Immunisation (CLCI), France
➡️   Tilen KozoleVice President of European Affairs, European Pharmaceutical Students' Association (EPSA), Belgium
➡️   Radovan Bogdanovic, Professor of Pediatrics & Pediatric Nephrologist, Paediatric Association of Serbia, Republic of Serbia
➡️   Mira Kojouharova, Consultant Epidemiologist, National Centre of Infectious and Parasitic Diseases, Bulgaria
➡️   Kare Molbak, Executive vice president, Statens Serum Institut. Professor, Faculty of Health and Medical Sciences, University of Copenhagen, Director, State Epidemiologist, Department of Infectious Disease Epidemiology, Statens Serum Institut, Denmark
➡️   Prof. Lieke Sanders, Professor in Pediatric Immunology & Infectious Diseases at Utrecht
University Medical Centre and Chief Scientific Officer at the Institute of Public health and the Environment, Netherlands
➡️   Hanna Nohynek, Chief Physician, Infectious Disease Control and Vaccinations Unit Department of Health Security, National Institute for Health and Welfare THL Helsinki, Finland
➡️   Roman Prymula, Professor of Preventive Medicine at School of Medicine, Charles University, Prague, Czech Republic
➡️   Prof. Marc Van Ranst, Professor, Department chair of the Department of Microbiology, Immunology and Transplantation, Head of the Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Belgium
➡️   Prof. Roy Philip, Consultant Neonatologist & Adjunct Professor of Neonatology, University Maternity Hospital Limerick GEMS, University of Limerick, Ireland
➡️   Gertraud Daye, Board Member of the NGO Committee on Ageing, UN, Vienna, Austria
➡️   Catherine Weil-Olivier, Honorary Professor of Pediatrics and Independent Expert, Paris VII University, France

 


THE 2019 MEETING REPORT

Click to download the report PDF or follow the link here to read it

WG1-Meningitis_REPORT_-_Google_Docs.jpg

 


If you want to join the Group and contribute to the work, follow the link here to submit your request
DoubleArrow.png 
If you want to suggest an activity or a campaign, follow to link here to submit your suggestion
 


SUGGESTED ACTION PLAN FOR 2020/2021

The action plan is a work in progress. We are currently collecting ideas and suggestions from all stakeholders and members on specifics campaigns that will be implemented in collaboration with the participating organisations and any other who wishes to contribute. 

Target 1: Improve European Surveillance
Need: Improved European surveillance/modelling and stronger local surveillance networks are needed. How can we help countries that are falling behind?   Picture_1.png

 

Proposed Action: Dedicated Focus Group on Improving European Surveillance & Modelling.

Target 2: Increase Adolescent Rates & Understanding the Effectiveness of Vaccinations in the Elderly

Need: Adolescents are a difficult target group to reach. How could we increase adolescent coverage rates, including the adolescent booster dose? How can we succeed in improving herd protection for teenagers, as well as the wider population? How effective is the direct targeting of the elderly with Meningitis Vaccinations?

  S-arrow2.png

  Proposed Actions: 1) A campaign to improve Adolescent Coverage, Booster Uptake and Herd Protection. 2) A Pilot Project looking at collecting scientific data regarding the effectiveness of vaccination in the elderly.
Target 3: Improving HCPs Knowledge and Utilising Allied HCPs as Advocates

Need - Meningococcal vaccinations are often viewed with less scepticism by the public due to the severe nature of the disease they protect against. How can we better utilise this power of positive public opinion? How can we improve the healthcare professional's knowledge of the latest surveillance data? How can we better work with Pharmacists and allied HCPs?

  S-arrow3.png

  Proposed Action: An educational campaign designed to use positive public opinion, improve HCP's knowledge and patient communication. Working with Pharmacists to promote meningitis vaccinations at every opportunity.
         



Access the
MEMBERS ONLY AREA

 

 

▷ Shape our activities
▷ Suggest campaigns
▷ Share experiences and ideas
▷ Working Groups Agendas
▷ Meeting Discussion Points

get updates

connect